drugset / Trial / NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the impact of rapid acceleration in the heart rate on the QT prolongation of quizartinib.
Timeline
- Start
- 2024-10-24
- Primary completion
- 2025-06-12
- Completion
- 2025-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quizartinib | Small molecule | 90 mg | Oral |
Indications
No indication recorded.